Literature DB >> 12406026

Post-transcriptional regulation of VEGF expression by oxidised LDL in human macrophages.

L Salomonsson1, S Pettersson, M C O Englund, O Wiklund, B G Ohlsson.   

Abstract

BACKGROUND: Accumulation of oxidised low density lipoproteins (oxLDL) in macrophages and their subsequent transformation into lipid-filled foam cells is generally considered an early event in atherosclerosis. Vascular Endothelial Growth Factor (VEGF) may contribute to atherogenesis through increased vascular permeability, chemoattraction towards monocytes and intraplaque vessel formation. In this study we investigate the effect and regulation of VEGF expression in human macrophages stimulated with oxLDL.
MATERIALS AND METHODS: Vascular Endothelial Growth Factor mRNA and protein expression was assayed using RT-PCR and ELISA, respectively. The activity of mitogen-activated protein kinases (MAPKs) was investigated using Western blots.
RESULTS: In human monocyte-derived macrophages, oxLDL significantly increased VEGF mRNA expression and subsequent protein secretion in a concentration-dependent manner after 6 h and 18 h, respectively. Using an in vitro mRNA decay assay, we show that this oxLDL-induced VEGF expression partly is regulated through increased stability of the VEGF mRNA. Involvement of MAPKs has previously been implicated in the stabilisation of VEGF mRNA. Activity of the p38 MAPK, but not the c-jun-N-terminal kinase (JNK), increased in macrophages stimulated with oxLDL (50 micro g mL-1) for 5-15 min. Preincubation with SB202190 (20 micro M), a specific inhibitor of p38 MAPK, significantly decreased the oxLDL-induced VEGF mRNA expression by 40%. The prolonged half-life of VEGF mRNA, induced by oxLDL, was not inhibited by SB202190.
CONCLUSIONS: OxLDL increases VEGF expression and p38 MAPK activity in human macrophages. The increased VEGF mRNA expression by oxLDL is mediated through at least two intracellular pathways, one involving p38 MAPK and another that independently of p38 MAPK activity increases VEGF mRNA stability.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406026     DOI: 10.1046/j.1365-2362.2002.01072.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  10 in total

1.  Production of vascular endothelial growth factors from human lung macrophages induced by group IIA and group X secreted phospholipases A2.

Authors:  Francescopaolo Granata; Annunziata Frattini; Stefania Loffredo; Rosaria I Staiano; Angelica Petraroli; Domenico Ribatti; Rob Oslund; Michael H Gelb; Gerard Lambeau; Gianni Marone; Massimo Triggiani
Journal:  J Immunol       Date:  2010-03-31       Impact factor: 5.422

2.  Humanin prevents intra-renal microvascular remodeling and inflammation in hypercholesterolemic ApoE deficient mice.

Authors:  Xin Zhang; Victor H Urbieta-Caceres; Alfonso Eirin; Caitlin C Bell; John A Crane; Hui Tang; Kyra L Jordan; Yun-Kyu Oh; Xiang-Yang Zhu; Michael J Korsmo; Adi R Bachar; Pinchas Cohen; Amir Lerman; Lilach O Lerman
Journal:  Life Sci       Date:  2012-07-20       Impact factor: 5.037

3.  7-ketocholesterol-induced inflammation: involvement of multiple kinase signaling pathways via NFκB but independently of reactive oxygen species formation.

Authors:  Ignacio M Larrayoz; Jiahn-Dar Huang; Jung Wha Lee; Iranzu Pascual; Ignacio R Rodríguez
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-16       Impact factor: 4.799

4.  LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma.

Authors:  David F Schaeffer; Maziar Riazy; Kuljit S Parhar; Johnny H Chen; Vincent Duronio; Tatsuya Sawamura; Urs P Steinbrecher
Journal:  J Lipid Res       Date:  2009-04-09       Impact factor: 5.922

5.  Activation of ETB receptors regulates the abundance of ET-1 mRNA in vascular endothelial cells.

Authors:  N Farhat; C C Matouk; A M Mamarbachi; P A Marsden; B G Allen; E Thorin
Journal:  Br J Pharmacol       Date:  2008-02-18       Impact factor: 8.739

Review 6.  Oxidative stress in angiogenesis and vascular disease.

Authors:  Young-Woong Kim; Tatiana V Byzova
Journal:  Blood       Date:  2013-12-03       Impact factor: 22.113

7.  AUF1/hnRNP D represses expression of VEGF in macrophages.

Authors:  Abigail Fellows; Mary E Griffin; Brenda L Petrella; Lihui Zhong; Fatemeh P Parvin-Nejad; Roy Fava; Peter Morganelli; R Brooks Robey; Ralph C Nichols
Journal:  Mol Biol Cell       Date:  2012-02-29       Impact factor: 4.138

Review 8.  Emerging Roles of Redox-Mediated Angiogenesis and Oxidative Stress in Dermatoses.

Authors:  Dehai Xian; Jing Song; Lingyu Yang; Xia Xiong; Rui Lai; Jianqiao Zhong
Journal:  Oxid Med Cell Longev       Date:  2019-04-16       Impact factor: 6.543

Review 9.  Reactive Oxygen Species and Oxidative Stress in Vascular-Related Diseases.

Authors:  Xin-Meng Cheng; Yu-Yuan Hu; Tao Yang; Nan Wu; Xue-Ning Wang
Journal:  Oxid Med Cell Longev       Date:  2022-04-04       Impact factor: 6.543

10.  RGD-modified multifunctional nanoparticles encapsulating salvianolic acid A for targeted treatment of choroidal neovascularization.

Authors:  Junxiu Zhang; Jingyi Zhu; Lingzhou Zhao; Ke Mao; Qing Gu; Dongli Li; Jinhua Zhao; Xingwei Wu
Journal:  J Nanobiotechnology       Date:  2021-07-02       Impact factor: 10.435

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.